[Effect of 4-acetyl-4-(3-chlorophenyl)-1-[3-(4-methylpiperazin)-propyl] piperidine trihydrochloride on the central nervous system, cardiovascular system and isolated organs of experimental animals].
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D005260:Female; D007421:Intestine, Small / Q000187:drug effects; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D010276:Parasympatholytics; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014590:Uterine Contraction / Q000187:drug effects
D010276:Parasympatholytics; D010880:Piperidines
Wpływ trójchlorowodorku 4-acetylo-4-(3-chlorofenylo)-1-[3-(4-methylopiperazyno)-propylo]-piperydyny na ośrodkowy układ nerwowy, układ sercowo-naczyniowy oraz wyosobnione narzady zwierzat doóswiadczalnych.